Studies on DRID epidemiology and interventions

Attachments

• EMCDDA systematic review of HCV among people who inject drugs in Europe - Marica Ferri, EMCDDA [English - 274.42 KB]
• The introduction of hepatitis C avidity and HBsAg testing into the Unlinked Anonymous Monitoring Survey of PWID in the UK - Vivian Hope, United Kingdom [English - 397.61 KB]
• A sero-behavioural survey of blood borne viruses among injectors of Image and Performance Enhancing Drugs - Vivian Hope, United Kingdom [English - 508.26 KB]
• DRID and psychiatric comorbidity among IDUs in Belgium, preliminary results of a serobehavioral prevalence study - Kaatje Bollaerts, Belgium [English - 351.3 KB]
• Changes and risks due to new injecting patterns in Hungary - Anna Tarjan, Hungary [English - 647.55 KB]
• The association between injecting drug use and HIV outcome measures in Latvia - Anda Karnite, Latvia [English - 600.62 KB]
• Comparing the HIV cohort study and DRID monitoring in Austria - Martin Busch, Austria [English - 201.56 KB]
• HIV-COBATEST Project and Pilot study for the implementation of rapid HIV and HCV test in Harm Reduction Programs for intravenous drug users - Laura Fernández, Spain [English - 1.19 MB]
• DRUCK-Study: sero-behavioural survey among injecting drug users in Germany using RDS, preliminary results of pilot study 2011 - Ruth Zimmerman, Germany [English - 871.57 KB]
• HCV treatment uptake among people who inject drugs: results from an EMCDDA expert meeting - Teodora Groshkova, EMCDDA [English - 1.4 MB]
• Recommendations for the management of hepatitis C virus infection among people who inject drugs - Geert Robaeys, INHSU [English - 2.26 MB]
• Improving Access to HIV/TB testing for marginalized groups - Jenneke van Ditzhuijzen [English - 3.68 MB]
• TB diagnosis and treatment among PWID: a Portuguese experience - Henrique Barros, Portugal [English - 1.52 MB]
• An integrated prevention initiative to stop HIV-1 outbreak among IDUs in Athens Metropolitan Area - Vana Sypsa, Greece [English - 733.6 KB]